Kunichika, H.; Minamiguchi, K.; Tachiiri, T.; Shimizu, K.; Taiji, R.; Yamada, A.; Nakano, R.; Irizato, M.; Yamauchi, S.; Marugami, A.;
et al. Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI. Cancers 2024, 16, 2275.
https://doi.org/10.3390/cancers16122275
AMA Style
Kunichika H, Minamiguchi K, Tachiiri T, Shimizu K, Taiji R, Yamada A, Nakano R, Irizato M, Yamauchi S, Marugami A,
et al. Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI. Cancers. 2024; 16(12):2275.
https://doi.org/10.3390/cancers16122275
Chicago/Turabian Style
Kunichika, Hideki, Kiyoyuki Minamiguchi, Tetsuya Tachiiri, Kozo Shimizu, Ryosuke Taiji, Aya Yamada, Ryota Nakano, Mariko Irizato, Satoshi Yamauchi, Aki Marugami,
and et al. 2024. "Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI" Cancers 16, no. 12: 2275.
https://doi.org/10.3390/cancers16122275
APA Style
Kunichika, H., Minamiguchi, K., Tachiiri, T., Shimizu, K., Taiji, R., Yamada, A., Nakano, R., Irizato, M., Yamauchi, S., Marugami, A., Marugami, N., Kishida, H., Nakagawa, H., Takewa, M., Kageyama, K., Yamamoto, A., Ueshima, E., Sofue, K., Kita, R.,
... Tanaka, T.
(2024). Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI. Cancers, 16(12), 2275.
https://doi.org/10.3390/cancers16122275